Changes in serum level of interleukin-32 and interleukin-6 in patients with chronic hepatitis B virus infection and its clinical significance
-
摘要: 目的探讨乙型肝炎患者血清白细胞介素(IL)-32和IL-6的变化及其临床意义。方法对92例乙型肝炎患者和30例健康者用ELISA法检测外周血清IL-32和IL-6水平变化。结果 (1)乙型肝炎组与对照组血清IL-32水平比较差异有统计学意义(F=108.494,P<0.001),急性乙型肝炎(AHB)组血清IL-32水平最高,慢性乙型肝炎(CHB)组随轻、中、重分型逐渐升高;乙型肝炎组与对照组血清IL-6水平比较差异有统计学意义(F=139.256,P<0.001),依AHB、CHB轻、中、重度逐渐升高。(2)HBV DNA阳性组IL-32、IL-6水平较阴性组为高,差异无统计学意义;高、中、低病毒载量组之间血清IL-32、IL-6水平比较差异无统计学意义(P>0.05)。(3)血清IL-32水平与IL-6水平呈正相关(r=0.70,P<0.05)。结论 (1)乙型肝炎患者外周血IL-32、IL-6水平升高,且随炎症程度加重呈上升趋势,推测IL-32、IL-6可能在炎症反应中发挥重要作用,IL-32、IL-6参与了乙型肝炎患者肝组织损伤及病情发展的过程。(2)血...Abstract: Objective To explore the changes of interleukin-32 and interleukin-6 in serum of patients with hepatitis B virus infection and its clinical significance.Methods The serum IL-32 and IL-6 of 92 HBV-infected patients and 30 healthy individuals were detected by ELISA.Results ⑴There was statistical difference in serum IL-32 between the patient in hepatitis B group and control group (F=108.494, P<0.001) .The level of serum IL-32 in patient with AHB is the highest among the subjects.The level of IL-32 in serum was gradually increased in patients with mild, moderate and severe chronic hepatitis B.The level of serum IL-6 in hepatitis B group has significant difference compare with control group (F=139.256, P<0.001) , moreover the level of IL-6 in serum gradually increased in patients with mild, moderate and severe chronic hepatitis B.⑵The serum levels of IL-32, IL-6 in the HBV-infected patients with HBV DNA positive group were higher than those observed in the control group, however, no significant difference was observed between the groups.The differences among various HBV viral load groups were also not statistically significant (P>0.05) .⑶The serum level of IL-32 was positively correlated with IL-6, the correlation coefficient r was 0.70 (P<0.05) .Conclusion ⑴The results indicate that the level of IL-32, IL-6 increases in HBV-infected patients.The level of IL-32, IL-6 increases with the aggravation of inflammation of liver, indicating that IL-32, IL-6 play an important role in inflammatory response and are responsible for liver inflammatory injury process and diseases progression in HBV-infected patients.⑵It seems that the changes in serum IL-32 and IL-6 were not related to the HBV replication status.
-
Key words:
- hepatitis B /
- interleukins /
- interleukin-6
-
[1]游晶, 庄林, 马永良, 等.慢性乙型肝炎的Th细胞亚群及相关细胞因子网络失衡[J].世界华人消化杂志, 2007, 15 (8) :791-799. [2]骆抗先.乙型肝炎基础和临床[M].北京:人民卫生出版社, 2006:183. [3]Netea MG, Azam T, Ferwerda G, et al.IL-32 synergizeswith nucleotide oligomerization domain (NOD) land (NOD) 2ligands for IL-1βand IL-6 production through a caspase1-dependent mechanism[J].Proc Natl Acad Sci U S A, 2005, 102 (45) :16309-16314. [4]中华医学会.病毒性肝炎防治方案[J].肝脏, 2000, 5 (4) :257-263. [5] 杨婉凤, 金树根, 汤小青, 等.肝病患者外周血CD4+、CD8+和CD16+56+细胞亚群变化[J].世界肿瘤杂志, 2002, 1 (2) :119-122. [6]梅小平, 敬雪明, 李健, 等.乙型肝炎患者血清IL-6、IL-8、TNF-α水平与肝损程度、HBV DNA含量的相关性分析[J].中国现代医学杂志, 2006, 16 (3) :395-397. [7]柳青, 冯桂湘, 林裕龙, 等.乙型肝炎患者血清中白细胞介素6、12水平的检测及其临床意义[J].第一军医大学学报, 2002, 21 (11) :858-859. [8]Dahl CA, Schall RP, He HL, et al.Identification of a novelgene expressed in activated natural killer cells and T cells[J].Immunol, 1992, 148 (2) :597-603. [9]Kim SH, Han SY, Azam TA, et al.Interleukin-32:a cytokine andinducer of TNF-α[J].Immunity, 2005, 22 (1) :131-142. [10]Netea MG, Azam T, Ferwerda G, et al.IL-32 synergizeswith nucleotide oligomerization domain (NOD) land (NOD) 2ligands for IL-1βand IL-6 production through a caspase1-dependent mechanism[J].Proc Natl Acad Sci U S A, 2005, 102 (45) :16309-16314. [11]Hirofumi S, Keishi F, Yumi Y, et al.Interactions betweenIL-32 and tumor necrosis factor a1pha contribute to theexacerbation of immune-inflammatory diseases[J].ArthritisRes Ther, 2006, 8 (6) :1-13. [12]Netea MG, Azam T, Lewis EC, et al.Mycobacteriumtuberculosis induces interleukin-32 production through acaspase-1/IL-18/interferon-γ-dependent mechanism[J].Plos Med, 2006, 3 (8) :e227. [13]Rasool ST, Tang H, Wu J, et al.Increased level of IL-32during human immunodeficiency virus infection suppressesHIV replication[J].Immunol lett, 2008, 117 (2) :161-167.
本文二维码
计量
- 文章访问数: 231
- HTML全文浏览量: 14
- PDF下载量: 148
- 被引次数: 0